Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I

AUTOR(ES)

Digicaylioglu, Murat

FONTE

National Academy of Sciences

RESUMO

Erythropoietin (EPO) and insulin-like growth factor I (IGF-I) are cytokines that inhibit neuronal apoptosis. However, their maximal antiapoptotic effect, even at high concentrations, is observed only when neurons are pretreated for several hours before insult. Here we show that simultaneous administration of EPO and IGF-I (EPO+IGF-I) eliminates the preincubation period required to prevent N-methyl-d-aspartate (NMDA)-induced apoptosis in cultured rat cerebrocortical neurons. The synergistic effect of EPO+IGF-I was mediated, at least in part, by activation of phosphatidylinositol 3-kinase (PI3-K). EPO+IGF-I synergistically activated Akt (protein kinase B), a downstream target of PI3-K, and prevented dephosphorylation of Akt. Overexpression of a dominant interfering form of Akt (dnAkt) abrogated EPO+IGF-I-mediated neuroprotection. EPO+IGF-I treatment did not prevent initial NMDA-induced caspase-3 activation, which was observed within 6 h of insult; however, EPO+IGF-I-treated neurons survived at least 2 days after NMDA insult. These cytokines prevented neuronal apoptosis downstream of caspase activation by facilitating association between X-linked inhibitor of apoptosis protein, an inhibitor of caspase proteolytic activity, and activated caspase-3. These results imply that EPO+IGF-I exert cooperative actions that afford acute neuroprotection via activation of the PI3-K-Akt pathway.

Documentos Relacionados

• Bioactive Insulin-Like Growth Factor-I in Obesity
• Isolation of the human insulin-like growth factor genes: insulin-like growth factor II and insulin genes are contiguous.
• Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
• The receptor for insulin-like growth factor II mediates an insulin-like response.
• The Role of Liver-Derived Insulin-Like Growth Factor-I